Different Efficacies of Erlotinib and Gefitinib in Taiwanese Patients with Advanced Non-small Cell Lung Cancer: A Retrospective Multicenter Study-Reference-Cited by-同舟云学术

Different Efficacies of Erlotinib and Gefitinib in Taiwanese Patients with Advanced Non-small Cell Lung Cancer: A Retrospective Multicenter Study

Published:2011-01 Issue:1 Volume:6 Page:148-155
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Fan Wen-Chien,Yu Chong-Jen,Tsai Chun-Ming,Huang Ming-Shyan,Lai Chun-Liang,Hsia Te-Chun,Tien Yin-Jing,Huang Shiang-Fen,Wu Chieh-Hung,Chou Kun-Ta,Lee Yu-Chin,Perng Reury-Perng,Chen Yuh-Min

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference36 articles.

1. Global cancer statistics;Parkin;CA Cancer J Clin,2005

2. Comparison of four chemotherapy regimens for advanced non-small cell lung cancer;Schiller;N Engl J Med,2002

3. Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy;Hanna;J Clin Oncol,2004

4. Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer);Thatcher;Lancet,2005

5. Erlotinib in previously treated non-small-cell lung cancer;Shepherd;N Engl J Med,2005

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Outcomes of concurrent versus sequential icotinib therapy and chemotherapy in advanced non‐small cell lung cancer with sensitive EGFR mutations;Clinical and Translational Science;2021-01-25

2. S‐1 plus cisplatin as first‐line treatment of patients with advanced non‐small cell lung cancer in Taiwan;Asia-Pacific Journal of Clinical Oncology;2020-04

3. Erlotinib versus gefitinib for brain metastases in Asian patients with exon 19 EGFR-mutant lung adenocarcinoma: a retrospective, multicenter study;BMC Pulmonary Medicine;2018-11-20

4. Efficacy and adverse events of five targeted agents in the treatment of advanced or metastatic non‐small‐cell lung cancer: A network meta‐analysis of nine eligible randomized controlled trials involving 5,059 patients;Journal of Cellular Physiology;2018-10-30

5. Gefitinib provides similar effectiveness and improved safety than erlotinib for east Asian populations with advanced non–small cell lung cancer: a meta-analysis;BMC Cancer;2018-08-02